Enteric nervous system manifestations of neurodegenerative disease

被引:92
作者
Chalazonitis, Alcmene [1 ]
Rao, Meenakshi [2 ]
机构
[1] Columbia Univ, Dept Pathol & Cell Biol, 630 West 168th St,P&S 11-511, New York, NY USA
[2] Columbia Univ, Dept Pediat, 622 West 168th St,PH 17, New York, NY 10027 USA
基金
美国国家卫生研究院;
关键词
Enteric nervous system; Parkinson's disease; Alzheimer's disease; Neurodegeneration; PATHOLOGICAL ALPHA-SYNUCLEIN; BETA PROTEIN-PRECURSOR; PARKINSONS-DISEASE; GASTROINTESTINAL DYSFUNCTION; IMMUNOHISTOCHEMICAL METHODS; DOPAMINERGIC-NEURONS; LEWY BODIES; MOTILITY; BRAIN; MODEL;
D O I
10.1016/j.brainres.2018.01.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurological disorders cause gastrointestinal (GI) symptoms that are debilitating and markedly diminish quality of life in patients. The enteric nervous system (ENS), the intrinsic nervous system of the GI tract that is often referred to as "the second brain", shares many features with the central nervous system. The ENS plays an essential role in regulating many GI functions including motility and fluid secretion. Enteric neuronal degeneration could therefore be responsible for the GI symptoms commonly observed in neurological conditions. Here we describe the organization and functions of the ENS and then review the evidence for ENS involvement in two common neurodegenerative disorders, Parkinson's disease (PD) and Alzheimer's disease (AD). Data from patients as well as animal models suggest that PD affects distinct subsets of neurons and glia in the ENS, and that the ENS may participate in the pathogenesis of this disorder. While there has been great enthusiasm for the possibility of sampling the ENS for diagnosis or therapeutic monitoring of PD, further work is needed to determine which enteric neurons are most affected and how ENS function could be modulated to ameliorate GI symptoms in patients. Although AD is far more common than PD and AD patients also experience GI symptoms, understanding of ENS dysfunction in AD is in its infancy. Much work remains to be done in both of these fields to determine how the ENS contributes to and/or is altered by these disorders, and how to target the ENS for more effective treatment of GI comorbidities. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:207 / 213
页数:7
相关论文
共 53 条
[1]   Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease [J].
Anderson, Grant ;
Noorian, All Reza ;
Taylor, Georgia ;
Anitha, Mallappa ;
Bernhard, Doug ;
Srinivasan, Shanthi ;
Greene, James G. .
EXPERIMENTAL NEUROLOGY, 2007, 207 (01) :4-12
[2]   Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss [J].
Annerino, Dana M. ;
Arshad, Shawn ;
Taylor, Georgia M. ;
Adler, Charles H. ;
Beach, Thomas G. ;
Greene, James G. .
ACTA NEUROPATHOLOGICA, 2012, 124 (05) :665-680
[3]   EXPRESSION PATTERNS OF BETA-AMYLOID PRECURSOR PROTEIN (BETA-APP) IN NEURAL AND NONNEURAL HUMAN TISSUES FROM ALZHEIMERS-DISEASE AND CONTROL SUBJECTS [J].
ARAI, H ;
LEE, VMY ;
MESSINGER, ML ;
GREENBERG, BD ;
LOWERY, DE ;
TROJANOWSKI, JQ .
ANNALS OF NEUROLOGY, 1991, 30 (05) :686-693
[4]   Evaluation of α-synuclein immunohistochemical methods used by invited experts [J].
Beach, Thomas G. ;
White, Charles L. ;
Hamilton, Ronald L. ;
Duda, John E. ;
Iwatsubo, Takeshi ;
Dickson, Dennis W. ;
Leverenz, James B. ;
Roncaroli, Federico ;
Buttini, Manuel ;
Hladik, Christa L. ;
Sue, Lucia I. ;
Noorigian, Joseph V. ;
Adler, Charles H. .
ACTA NEUROPATHOLOGICA, 2008, 116 (03) :277-288
[5]   Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects [J].
Beach, Thomas G. ;
Corbille, Anne-Gaelle ;
Letournel, Franck ;
Kordower, Jeffrey H. ;
Kremer, Thomas ;
Munoz, David G. ;
Intorcia, Anthony ;
Hentz, Joseph ;
Adler, Charles H. ;
Sue, Lucia I. ;
Walker, Jessica ;
Serrano, Geidy ;
Derkinderen, Pascal .
JOURNAL OF PARKINSONS DISEASE, 2016, 6 (04) :761-770
[6]   Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology [J].
Braak, H ;
de Vos, RAI ;
Bohl, J ;
Del Tredici, K .
NEUROSCIENCE LETTERS, 2006, 396 (01) :67-72
[7]   Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update [J].
Brichta, Lars ;
Greengard, Paul .
FRONTIERS IN NEUROANATOMY, 2014, 8
[8]   Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms [J].
Cersosimo, Maria G. ;
Raina, Gabriela B. ;
Pecci, Cristina ;
Pellene, Alejandro ;
Calandra, Cristian R. ;
Gutierrez, Cristiam ;
Micheli, Federico E. ;
Benarroch, Eduardo E. .
JOURNAL OF NEUROLOGY, 2013, 260 (05) :1332-1338
[9]   Pathological correlates of gastrointestinal dysfunction in Parkinson's disease [J].
Cersosimo, Maria G. ;
Benarroch, Eduardo E. .
NEUROBIOLOGY OF DISEASE, 2012, 46 (03) :559-564
[10]   Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism [J].
Chaumette, T. ;
Lebouvier, T. ;
Aubert, P. ;
Lardeux, B. ;
Qin, C. ;
Li, Q. ;
Accary, D. ;
Bezard, E. ;
des Varannes, S. Bruley ;
Derkinderen, P. ;
Neunlist, M. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (02) :215-222